ES406464A1 - Bioerodible ocular device - Google Patents

Bioerodible ocular device

Info

Publication number
ES406464A1
ES406464A1 ES406464A ES406464A ES406464A1 ES 406464 A1 ES406464 A1 ES 406464A1 ES 406464 A ES406464 A ES 406464A ES 406464 A ES406464 A ES 406464A ES 406464 A1 ES406464 A1 ES 406464A1
Authority
ES
Spain
Prior art keywords
drug
eye
bioerodible
administration
ocular device
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES406464A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alza Corp
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of ES406464A1 publication Critical patent/ES406464A1/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A61F9/0017Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • A61K9/0051Ocular inserts or implants

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Bioerodible ocular device for continuous and controlled administration of a predetermined dosage of drug to the eye, comprising one or more drug reservoirs confined within a bioerodible material controlling the rhythm of drug release, which continuously dosages the flow of a therapeutically amount effective drug from the reservoir to the eye at a controlled rate for a prolonged period of time, which device is initially adapted for insertion and retention in the cul-de-sac of the eye and is bioerosed in the environment of the eye simultaneously with the administration, or at a later time, of the predetermined dose of the drug. (Machine-translation by Google Translate, not legally binding)
ES406464A 1971-09-09 1972-09-07 Bioerodible ocular device Expired ES406464A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17912971A 1971-09-09 1971-09-09

Publications (1)

Publication Number Publication Date
ES406464A1 true ES406464A1 (en) 1975-10-01

Family

ID=22655344

Family Applications (1)

Application Number Title Priority Date Filing Date
ES406464A Expired ES406464A1 (en) 1971-09-09 1972-09-07 Bioerodible ocular device

Country Status (19)

Country Link
JP (1) JPS5820930B2 (en)
AR (1) AR201907A1 (en)
AT (1) AT337889B (en)
AU (1) AU471934B2 (en)
BE (1) BE788575A (en)
BR (1) BR7206210D0 (en)
CA (1) CA989732A (en)
CH (1) CH576793A5 (en)
DE (1) DE2243986C2 (en)
DK (1) DK134465B (en)
ES (1) ES406464A1 (en)
FR (1) FR2157798B1 (en)
GB (1) GB1372944A (en)
IE (1) IE38145B1 (en)
IL (1) IL40223A (en)
IT (1) IT983227B (en)
NL (1) NL7212272A (en)
SE (1) SE431160B (en)
ZA (1) ZA725758B (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH17900A (en) * 1979-09-12 1985-01-25 Lilly Co Eli Growth promotant controlled release formulations and method of treatment
NZ194898A (en) * 1979-09-12 1983-04-12 Lilly Co Eli Controlled release parasiticidal formulation containing fenbendazole dispersed in lactic acid-glycolic acid copolymer
DE3601787A1 (en) * 1986-01-22 1987-07-23 Cox Kirsten METHOD FOR APPLICATION OF ACTIVE SUBSTANCES AND APPLICATOR SUITABLE FOR THIS
CA1311686C (en) * 1986-06-25 1992-12-22 John Weldon Shell Controlled release bioerodible drug delivery system
US4853224A (en) * 1987-12-22 1989-08-01 Visionex Biodegradable ocular implants
DE19756314C2 (en) * 1997-12-12 2000-06-29 Roland Bodmeier Preparation with extended residence time at the application site
GB0122318D0 (en) * 2001-09-14 2001-11-07 Novartis Ag Organic compounds
US20050244478A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Anti-excititoxic sustained release intraocular implants and related methods
US8591885B2 (en) 2004-04-30 2013-11-26 Allergan, Inc. Carbonic anhydrase inhibitor sustained release intraocular drug delivery systems
AU2010256558B2 (en) * 2009-06-03 2013-10-03 Forsight Labs, Llc Anterior segment drug delivery
RU2740680C2 (en) * 2011-09-14 2021-01-19 Форсайт Вижн5, Инк. Eye inserter device and methods
EP2911623B1 (en) 2012-10-26 2019-08-14 Forsight Vision5, Inc. Ophthalmic system for sustained release of drug to eye
US20160296532A1 (en) 2015-04-13 2016-10-13 Forsight Vision5, Inc. Ocular Insert Composition of a Semi-Crystalline or Crystalline Pharmaceutically Active Agent
CN119950174B (en) * 2025-02-20 2025-11-21 中国人民解放军陆军军医大学第一附属医院 A hydrophilic eye care patch device capable of being partially and gradually soaked in liquid.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3416530A (en) * 1966-03-02 1968-12-17 Richard A. Ness Eyeball medication dispensing tablet
US3485244A (en) * 1966-12-15 1969-12-23 Hyman Rosen Eye applicator
US3618604A (en) * 1969-06-09 1971-11-09 Alza Corp Ocular insert

Also Published As

Publication number Publication date
AR201907A1 (en) 1975-04-30
JPS4836993A (en) 1973-05-31
DK134465C (en) 1977-04-18
AU471934B2 (en) 1976-05-06
ATA779372A (en) 1976-11-15
DK134465B (en) 1976-11-15
FR2157798B1 (en) 1975-06-20
BR7206210D0 (en) 1973-07-17
JPS5820930B2 (en) 1983-04-26
IE38145B1 (en) 1978-01-04
AT337889B (en) 1977-07-25
ZA725758B (en) 1973-05-30
IL40223A (en) 1974-11-29
SE431160B (en) 1984-01-23
DE2243986A1 (en) 1973-03-29
IL40223A0 (en) 1972-10-29
BE788575A (en) 1973-01-02
AU4602572A (en) 1974-03-07
IT983227B (en) 1974-10-31
FR2157798A1 (en) 1973-06-08
CH576793A5 (en) 1976-06-30
CA989732A (en) 1976-05-25
NL7212272A (en) 1973-03-13
DE2243986C2 (en) 1982-12-23
IE38145L (en) 1973-03-09
GB1372944A (en) 1974-11-06

Similar Documents

Publication Publication Date Title
SE7611944L (en) OGON INSERT FOR TREATMENT OF WATER DEFICIT IN TORRA OGON
ES8102812A1 (en) Implantable infusion device.
NL189747C (en) DOSAGE UNIT FOR CONTROLLED DELIVERY OF MEDICINES.
IL46521A0 (en) Unit for infusing a liquid drug continuously into a patient at a controlled rate
DK126614B (en) Medicine holder for controlled release in the uterus of a biologically active substance.
IT1042261B (en) DEVICE FOR SYRINGE ORGANITIES OR SIMILAR LOCATED WITHIN THE HUMAN BODY
DK132012C (en) APPARATUS FOR DELIVERING A FINE DISTRIBUTED MEDICINE INTO A BODY HOLE
MX9203556A (en) A DOSAGE FORM TO ADMINISTER THE BENEFICIAL DRUGS PSEUDOEFEDRINE AND BROMOFENIRAMINA.
NO138189C (en) CARRIER FOR THERAPEUTICALLY ACTIVE COMPOUNDS, WITH REGULAR SUGGESTED, PROGRAMMED MEDICINAL DELIVERY
IT1119327B (en) IMPLANTABLE INFUSION DEVICE IN THE BODY OF THE PATIENT
MX9203554A (en) AN OSMOTIC DEVICE TO ADMINISTER DOXAZOSIN
ES276693A1 (en) A device for administering gas to a patient (Machine-translation by Google Translate, not legally binding)
ES402773A1 (en) Device for applying medical substances to the nasal mucosa
IL40223A (en) A bioerodible ocular device for the controlled continuous administration of a predetermined dosage of drug to the eye
ES407155A1 (en) A dispenser device for the continuous administration of an active agent at controlled speed. (Machine-translation by Google Translate, not legally binding)
FR2113778A1 (en) Drug-delivery system
ES218725U (en) A perfected inhalation device. (Machine-translation by Google Translate, not legally binding)
FR2064794A5 (en) Method and device for the administration of medicaments by inhalation
ZA703978B (en) Device for subcutaneous administration of biologically active substances
ES171385U (en) Medical bandage. (Machine-translation by Google Translate, not legally binding)
KR900701311A (en) How to treat squamous cell carcinoma by administering recombinant human α-interferon intralesionally
ES171914U (en) Eye insert. (Machine-translation by Google Translate, not legally binding)
FR1469342A (en) Unit dose enhanced for drug delivery
Plzak et al. A report on experience with anafranilin therapy in endogenous depressions.
GR33093B (en) DEVICE FOR THE ADMINISTRATION OF ACTIVE SUBSTANCES OF WOMEN'S OWN CONTRACTING MEDIA.